 |
Diazepam viscous solution for rectal administration |
|---|---|
| Trade Name | |
| Orphan Indication | For the management of selected, refractory, patients with epilepsy, on stable regimens of antiepileptic drugs (AEDs), who require intermittent use of diazepam to control bouts of increased seizure activity |
| USA Market Approval | USA |
| USA Designation Date | 1992-02-25 00:00:00 |
| Sponsor | Valeant Pharmaceuticals;3300 Hyland Avenue;Costa Mesa, California, 92626 |
